Amount Raised
$15 Million
Round Type
series b
Description
Beijing-headquartered Genfine Biotech (Beijing) Co., Ltd has raised 100 million yuan ($15 million) in its Series B round of financing jointly led by state-backed China Merchants Group’s China Merchants Securities (CMS) and China Merchants Securities Capital (CMSC), per a company statement.
FundzWatch™ Score
69
Medium Activity
Buyer Intent Analysis
Get personalized insights on buying likelihood
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech